Viral Infection Causes Rapid Sensitization to Lipopolysaccharide: Central Role of IFN-αβ
LPS is the major active agent in the pathogenesis of Gram-negative septic shock. In this report we have studied the influence of concurrent viral infection on the outcome of LPS-induced shock. We find that infection with vesicular stomatitis virus sensitizes mice to LPS at an early time point follow...
Gespeichert in:
Veröffentlicht in: | The Journal of immunology (1950) 2001-01, Vol.166 (2), p.982-988 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | LPS is the major active agent in the pathogenesis of Gram-negative septic shock. In this report we have studied the influence of concurrent viral infection on the outcome of LPS-induced shock. We find that infection with vesicular stomatitis virus sensitizes mice to LPS at an early time point following infection. Treatment of mice with the chemical IFN inducer, polyinosinic:polycytidylic acid, has a similar effect. This hypersensitivity to LPS correlated with hyperproduction of TNF-α in vivo. The cellular and molecular mechanisms underlying this phenomenon were investigated using Ab-depleted and gene-targeted mice. Our results revealed that while NK cell depletion and elimination of IFN-γ partially protected against the sensitizing effects of vesicular stomatitis virus and polyinosinic:polycytidylic acid, the most striking effect was observed in IFN-αβR-deficient mice. Thus hyperproduction of TNF-α was completely abrogated in IFN-αβR-deficient mice, indicating that the principal mechanism underlying rapid virus-induced sensitization to LPS is an IFN-αβ-mediated priming of mice for an augmented production of TNF-α in response to LPS. This conclusion was further supported by the finding that pretreatment of mice with rIFN-αβ mimicked the effect of viral infection. In conclusion, our results reveal a previously unrecognized proinflammatory effect of IFN-αβ and point to a new pathway through which viral infection may influence the outcome of concurrent bacterial infection. |
---|---|
ISSN: | 0022-1767 1550-6606 |
DOI: | 10.4049/jimmunol.166.2.982 |